The success of orthotopic liver transplantation (OLT) has created a demand which exceeds the availability of donor livers, medical capacities, and financial resources. It is estimated that the number of potential OLT candidates is 4,000-10,000 per year. However, donor availability currently meets approximately 1/3 of the estimated need. Because we cannot transplant all patients with end-stage liver disease, we must develop rational guidelines so that those who are transplanted have the greatest opportunity for a successful outcome. To meet this challenge we have developed and validated survival models for primary biliary cirrhosis (PBC) and primary sclerosing cholangitis (PSC), and determined the efficacy of OLT for patients with these diseases. We now plan to: 1) develop methods for patient selection and OLT timing that maximize patient and graft survival; 2) determine the effect of optimal selection and timing on cost and quality of life. To achieve these goals we will: 1) combine our established PBC/PSC natural history models with proposed models of patient and graft survival and post surgical complications; 2) measure the change in quality of life pre and post OLT and determine the variables that influence quality of life; and 3) determine the cost and economic utility of OLT. A major benefit of our research will be to enable patients to become better informed participants in their health care. Our models will predict a patient's survival, surgical complications, quality of life, and costs, thereby allowing patients and health care providers to make more informed health care decisions. Ultimately these models will optimize timing of OLT by taking into consideration the patient's current status and risk of disease progression versus operative mortility , cost, and quality of life. Finally, this proposal establishes a research framework that may be applied to other categories of liver disease and other transplanted organs. Our proposal combines the strengths of four major OLT centers: University of Pittsburgh, Baylor University Medical Center, University of Washington at Seattle, and the Mayo Clinic. Combining these databases will assure geographic diversification and adequate patient numbers for mathematical modeling.

Agency
National Institute of Health (NIH)
Institute
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Type
Research Project (R01)
Project #
5R01DK034238-09
Application #
2139267
Study Section
Epidemiology and Disease Control Subcommittee 2 (EDC)
Project Start
1986-01-15
Project End
1996-11-30
Budget Start
1994-12-01
Budget End
1995-11-30
Support Year
9
Fiscal Year
1995
Total Cost
Indirect Cost
Name
Mayo Clinic, Rochester
Department
Type
DUNS #
City
Rochester
State
MN
Country
United States
Zip Code
55905
Heo, Nae-Yun; Mannalithara, Ajitha; Kim, Donghee et al. (2018) Long-term Patient and Graft Survival of Kidney Transplant Recipients With Hepatitis C Virus Infection in the United States. Transplantation 102:454-460
Kwong, Allison J; Kim, W Ray; Flemming, Jennifer A (2018) De Novo Hepatocellular Carcinoma Among Liver Transplant Registrants in the Direct Acting Antiviral Era. Hepatology 68:1288-1297
Yang, Ju Dong; Mannalithara, Ajitha; Piscitello, Andrew J et al. (2018) Impact of surveillance for hepatocellular carcinoma on survival in patients with compensated cirrhosis. Hepatology 68:78-88
Kwong, Allison J; Goel, Aparna; Mannalithara, Ajitha et al. (2018) Improved posttransplant mortality after share 35 for liver transplantation. Hepatology 67:273-281
Allen, Alina M; Heimbach, Julie K; Larson, Joseph J et al. (2018) Reduced Access to Liver Transplantation in Women: Role of Height, MELD Exception Scores, and Renal Function Underestimation. Transplantation 102:1710-1716
Kwong, Allison; Kim, W Ray; Mannalithara, Ajitha et al. (2018) Decreasing mortality and disease severity in hepatitis C patients awaiting liver transplantation in the United States. Liver Transpl 24:735-743
Flemming, Jennifer A; Kim, W Ray; Brosgart, Carol L et al. (2017) Reduction in liver transplant wait-listing in the era of direct-acting antiviral therapy. Hepatology 65:804-812
Kim, Sang Gyune; Larson, Joseph J; Lee, Ji Sung et al. (2017) Beneficial and harmful effects of nonselective beta blockade on acute kidney injury in liver transplant candidates. Liver Transpl 23:733-740
Allen, Alina M; Kim, W Ray; Larson, Joseph J et al. (2016) The Epidemiology of Liver Diseases Unique to Pregnancy in a US Community: A Population-Based Study. Clin Gastroenterol Hepatol 14:287-94.e1-2
Yang, Ju Dong; Mohamed, Hager Amed; Cvinar, Jessica L et al. (2016) Diabetes Mellitus Heightens the Risk of Hepatocellular Carcinoma Except in Patients With Hepatitis C Cirrhosis. Am J Gastroenterol 111:1573-1580

Showing the most recent 10 out of 95 publications